Indian drugmakers have had a hard time tapping into the Chinese market. But U.S. pricing pressure and China's recent policy changes aimed at further bringing down drug costs have intrigued some top Indian players.
Shanghai Desano Chemical Pharmaceutical Co. Ltd. Receives FDA Warning Letter